Form 8-K - Current report:
SEC Accession No. 0001193125-20-315323
Filing Date
2020-12-11
Accepted
2020-12-11 06:11:01
Documents
21
Period of Report
2020-12-09
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d67428d8k.htm   iXBRL 8-K 34785
2 EX-1.1 d67428dex11.htm EX-1.1 155346
3 EX-4.1 d67428dex41.htm EX-4.1 92679
4 EX-5.1 d67428dex51.htm EX-5.1 12357
5 EX-99.1 d67428dex991.htm EX-99.1 10448
6 EX-99.2 d67428dex992.htm EX-99.2 10649
10 GRAPHIC g67428dsp35.jpg GRAPHIC 2280
11 GRAPHIC g67428dsp36.jpg GRAPHIC 1785
12 GRAPHIC g67428dsp37.jpg GRAPHIC 5940
13 GRAPHIC g67428dsp38.jpg GRAPHIC 3622
  Complete submission text file 0001193125-20-315323.txt   544820

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA onct-20201209.xsd EX-101.SCH 3073
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20201209_lab.xml EX-101.LAB 18139
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20201209_pre.xml EX-101.PRE 11410
14 EXTRACTED XBRL INSTANCE DOCUMENT d67428d8k_htm.xml XML 3414
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 201382192
SIC: 2834 Pharmaceutical Preparations